| |
| |
| |
| |
| | | |
|
PR:000050281 | rep gene proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| | | | |
|
PR:000050282 | ORF1a proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| | | | |
|
PR:000050283 | ORF1ab proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| |
| | | | | |
|
PR:000050286 | proofreading exoribonuclease nsp14 (SARS-CoV-2) | | | | | |
| | | | | |
|
PR:000050287 | uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | | |
|
PR:000050262 | severe acute respiratory syndrome coronavirus 2 protein | | | | | |
| |
| | | | | |
|
PR:000050281 | rep gene proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| | | | | | |
|
PR:000050282 | ORF1a proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| | | | | | |
|
PR:000050283 | ORF1ab proteolytic cleavage product (SARS-CoV-2) | | | | | |
| |
| |
| |
| | | | | | | |
|
PR:000050286 | proofreading exoribonuclease nsp14 (SARS-CoV-2) | | | | | |
| | | | | | | |
|
PR:000050287 | uridylate-specific endoribonuclease nsp15 (SARS-CoV-2) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |